160 related articles for article (PubMed ID: 17382387)
1. Epigenetic regulation of PRAME gene in chronic myeloid leukemia.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Jose-Eneriz ES; Garate L; Cordeu L; Cervantes F; Prosper F; Heiniger A; Torres A
Leuk Res; 2007 Nov; 31(11):1521-8. PubMed ID: 17382387
[TBL] [Abstract][Full Text] [Related]
2. Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia.
Ortmann CA; Eisele L; Nückel H; Klein-Hitpass L; Führer A; Dührsen U; Zeschnigk M
Ann Hematol; 2008 Oct; 87(10):809-18. PubMed ID: 18587578
[TBL] [Abstract][Full Text] [Related]
3. PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literature.
Paydas S; Tanriverdi K; Yavuz S; Seydaoglu G
Leuk Res; 2007 Mar; 31(3):365-9. PubMed ID: 16914202
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia.
Qian J; Wang YL; Lin J; Yao DM; Xu WR; Wu CY
Eur J Haematol; 2009 Feb; 82(2):119-23. PubMed ID: 19018866
[TBL] [Abstract][Full Text] [Related]
5. Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules.
Schmitt M; Li L; Giannopoulos K; Chen J; Brunner C; Barth T; Schmitt A; Wiesneth M; Döhner K; Döhner H; Greiner J
Exp Hematol; 2006 Dec; 34(12):1709-19. PubMed ID: 17157168
[TBL] [Abstract][Full Text] [Related]
6. Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia.
Luetkens T; Schafhausen P; Uhlich F; Stasche T; Akbulak R; Bartels BM; Hildebrandt Y; Gontarewicz A; Kobold S; Meyer S; Gordic M; Bartels K; Lajmi N; Cao Y; Kröger N; Bokemeyer C; Brümmendorf TH; Atanackovic D
Leuk Res; 2010 Dec; 34(12):1647-55. PubMed ID: 20409582
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression level of SH2 domain-containing protein tyrosine phosphatase-1 (Shp1) is associated with progression of chronic myeloid leukaemia.
Amin HM; Hoshino K; Yang H; Lin Q; Lai R; Garcia-Manero G
J Pathol; 2007 Aug; 212(4):402-10. PubMed ID: 17503411
[TBL] [Abstract][Full Text] [Related]
8. The role of methylation in CML.
Rachmilewitz EA
Przegl Lek; 2000; 57 Suppl 1():25-6. PubMed ID: 10822991
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between blast crisis of chronic myeloid leukemias and abnormality of p16 and calcitonin genes].
Xu D; Hong W; Wang S
Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):151-3. PubMed ID: 11776646
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3.
Yang MY; Chang JG; Lin PM; Tang KP; Chen YH; Lin HY; Liu TC; Hsiao HH; Liu YC; Lin SF
Cancer Sci; 2006 Dec; 97(12):1298-307. PubMed ID: 16999817
[TBL] [Abstract][Full Text] [Related]
12. Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; San Jose-Eneriz E; Garate L; Cordeu L; Cervantes F; Prosper F; Heiniger A; Torres A
Leuk Res; 2008 Mar; 32(3):487-90. PubMed ID: 17765966
[TBL] [Abstract][Full Text] [Related]
13. Correlation between preferentially expressed antigen of melanoma and tumour necrosis factor-related apoptosis-inducing ligand gene expression in different types of leukaemia patients.
Zhang W; Chi K; Zhang Y; Ma B; Shi J; Chen Y; Lei P; Li Y; Sun K
Acta Haematol; 2013; 130(4):297-304. PubMed ID: 24008770
[TBL] [Abstract][Full Text] [Related]
14. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
[TBL] [Abstract][Full Text] [Related]
15. Hypomethylation of PRAME is responsible for its aberrant overexpression in human malignancies.
Schenk T; Stengel S; Goellner S; Steinbach D; Saluz HP
Genes Chromosomes Cancer; 2007 Sep; 46(9):796-804. PubMed ID: 17534929
[TBL] [Abstract][Full Text] [Related]
16. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
[TBL] [Abstract][Full Text] [Related]
17. [Study of calcitonin gene methylation in chronic myeloid leukemia by using Hpa II-PCR].
Tan B; Cao P; Qi Z
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):371-3. PubMed ID: 12080652
[TBL] [Abstract][Full Text] [Related]
18. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
[TBL] [Abstract][Full Text] [Related]
19. mRNA expression of MAGE-A3 gene in leukemia cells.
Martínez A; Olarte I; Mergold MA; Gutiérrez M; Rozen E; Collazo J; Amancio-Chassin O; Ordóñez RM; Montesinos JJ; Mayani H; McCurdy DK; Ostrosky-Wegman P; Garrido-Guerrero E; Miranda EI
Leuk Res; 2007 Jan; 31(1):33-7. PubMed ID: 16806467
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemia.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; San Jose-Eneriz E; Garate L; Cordeu L; Cervantes F; Prosper F; Heiniger A; Torres A
Haematologica; 2007 Feb; 92(2):153-62. PubMed ID: 17296563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
